Format

Send to

Choose Destination
J Eur Acad Dermatol Venereol. 2017 Mar;31(3):450-454. doi: 10.1111/jdv.13941. Epub 2016 Sep 19.

Lentigo maligna - anatomic location as a potential risk factor for recurrences after non-surgical treatment.

Author information

1
Department of Dermatology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
2
Department of Pathology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.

Abstract

BACKGROUND:

A higher incidence of lentigo maligna (LM) recurrences on the nose was previously observed in our cohort after non-surgical treatment.

OBJECTIVES:

To determine histological parameters that might be related to the previously observed higher incidence of LM recurrences on the nose after non-surgical treatment.

METHODS:

We randomly selected 22 surgical specimens of LM on the nose and 22 on the cheek. Histopathological analysis was performed on haematoxylin and eosin stained and microphthalmia transcription factor immunohistochemically stained slides. The number of pilosebaceous units (PSU) per mm, maximum depth of atypical melanocytes along the skin appendages and maximum depth of the PSU itself were determined.

RESULTS:

The nose had a significantly higher density of PSU than the cheek. The atypical melanocytes extended deeper along the PSU on the nose with a mean (SD) depth of 1.29 mm (0.48) vs. a mean depth of 0.72 mm (0.30) on the cheek (P < 0.001). The maximum depth of the PSU on the nose was greater than on the cheek, mean (SD) depth of 2.28 mm (0.41) vs. 1.65 mm (0.82) (P = 0.003).

CONCLUSIONS:

The higher recurrence risk of LM on the nose after non-surgical treatment that we previously observed in our cohort is most likely based on a higher density of atypical melanocytes and also their deeper extension into the follicles. These results shed more light on our previous findings and learn that anatomical location is relevant for the risk of recurrence of LM after non-surgical treatment.

PMID:
27557425
PMCID:
PMC5363235
DOI:
10.1111/jdv.13941
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center